Dr Alexandre Slater MSci (Hons), PhD

Dr Alexandre Slater

Department of Cardiovascular Sciences
British Heart Foundation Intermediate Research Fellow

Contact details

Address
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Alex Slater is a British Heart Foundation Intermediate Research Fellow at Cardiovascular Sciences, University of Birmingham

Alex Slater’s background is in structural biology and studying protein - protein interactions. His current interests involve using a mixture of x-ray crystallography and cryo-electron microscopy to study the structure of platelet receptors in complex with inhibitory and activating ligands. This knowledge is then used for the development and characterization of novel anti-thrombotic therapies.

Qualifications

  • PhD in Biological chemistry (2017)
  • MSci in Biochemistry and Biological chemistry (2013)

Biography

Alex Slater undertook his undergraduate studies at the University of Nottingham in ‘Biochemistry and Biological Chemistry’. He followed this up with a PhD at the University of Nottingham studying protein - protein interactions within the contact pathway. Here he gained experience in multiple biophysical techniques including x-ray crystallography and nuclear magnetic resonance.

In 2017, he moved to a COMPARE post-doc position between the Universities of Nottingham and Birmingham under the supervision of Professor Jonas Emsley and Dr Natalie Poulter studying the GPIb-V-IX receptor by super resolution microscopy. He then moved to Professor Steve Watson's group from 2018-2022 where he studied the structure of platelet receptor GPVI.

His current position as a British Heart Foundation funded Research Fellow at the University of Birmingham continues his interest in platelet receptor structure, with a particular focus on studying their structure within the membrane as part of larger multi-chain signalling complexes.

Alex Slater has authored and co-authored over 20 publications in leading journals such as Blood, and has deposited a series of crystal structures onto the protein data bank.

Postgraduate supervision

Alex Slater supervises PhD students within the Birmingham Platelet lab in protein production, protein interaction assays and x-ray crystallography. These include Foteini Damaskinaki who submitted her thesis in 2022.

Research

Birmingham Platelet Group - Alexandre Slater

Alex Slater's fellowship focuses on studying the full-length structures of platelet receptor GPVI and identifying novel regions that can be targeted using biologics. The aim is to generate novel GPVI inhibitors that can inhibit GPVI activation by all ligands.

In addition, Alex Slater is involved in various projects aiming to increase the efficacy of existing GPVI nanobody inhibitors to be used to target acute coronary syndromes. 

Alex Slater is involved in a collaborative project with Prof Julie Rayes to develop inhibitors targeting the action of damage associated molecular patterns on inflammation during sepsis.

Other activities

  • School of Medical Sciences chemical safety officer
  • Member of the platelet society working group committee 
  • Host of the platelet society 'probably platelets' podcast
  • Registered mentor for the Platelet Society

Publications

Recent publications

Article

Noureddine, M, Mikolajek, H, Cowieson, N, Pinotsis, N, Robinson, P, Slater, A, Redwood, C, Loughna, S, Denning, C, Mohammed, F & Gehmlich, K 2026, 'Comprehensive biophysical and structural profiling of alpha-actinin-2 variants reveals mechanistic diversity in hypertrophic cardiomyopathy', Nature Communications, vol. 17, 6127. https://doi.org/10.1038/s41467-026-75392-z

Slater, A, Pan, H-Y, Ho, T-H, Martin, EM, Watson, SP, Pike, JA, Poulter, NS & Thomas, SG 2026, 'Nanobodies to GPVI as alternative reagents for platelet spreading', Platelets, vol. 37, no. 1, 2653068. https://doi.org/10.1080/09537104.2026.2653068

Clark, JC, Martin, EM, Slater, A, Calebiro, D, Koszegi, Z & Watson, SP 2026, 'Receptor homodimerisation significantly prolongs the lifetime of ligand-induced crosslinking of CLEC-2 but not GPVI', Blood vessels, thrombosis & hemostasis. https://doi.org/10.1016/j.bvth.2026.100160

Noureddine, M, Jones, BAI, Oliobi, OCM, Beckingham, R, Ehler, E, Mikolajek, H, Cowieson, N, Robinson, P, Redwood, C, Slater, A, Loughna, S, Denning, C, Myles, R, Coats, C, Mohammed, F & Gehmlich, K 2026, 'Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathy', Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2026.06.009

Xu, R-G, Tiede, C, Calabrese, AN, Cheah, LT, Adams, TL, Gauer, JS, Hindle, MS, Webb, BA, Yates, DM, Slater, A, Duval, C, Naseem, KM, Herr, AB, Tomlinson, DC, Watson, SP & Ariëns, RAS 2024, 'Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer', Blood Advances, vol. 8, no. 15, pp. 3917-3928. https://doi.org/10.1182/bloodadvances.2024012689

Slater, A, Khattak, S & Thomas, MR 2024, 'GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease', European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae018

Wang, X, Slater, A, Lee, SC, Harrison, N, Pollock, NL, Bakker, SE, Navarro, S, Nieswandt, B, Dafforn, TR, García, Á, Watson, SP & Tomlinson, MG 2024, 'Purification and characterisation of the platelet-activating GPVI/FcRγ complex in SMALPs', Archives of Biochemistry and Biophysics, vol. 754, 109944. https://doi.org/10.1016/j.abb.2024.109944

Martin, E, Clark, J, Montague, S, Moran, LA, Di, Y, Bull, LJ, Whittle, L, Raka, F, Buka, R, Zafar, I, Kardeby, C, Slater, A & Watson, S 2024, 'Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand', Journal of Thrombosis and Haemostasis, vol. 22, no. 1, pp. 271-285. https://doi.org/10.1016/j.jtha.2023.09.026

Alenazy, FO, Harbi, MH, Kavanagh, DP, Price, J, Brady, P, Hargreaves, O, Harrison, P, Slater, A, Tiwari, A, Nicolson, PLR, Connolly, DL, Kirchhof, P, Kalia, N, Jandrot-Perrus, M, Mangin, PH, Watson, SP & Thomas, MR 2023, 'Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 11, pp. 3236-3251. https://doi.org/10.1016/j.jtha.2023.07.018

Damaskinaki, F-N, Jooss, NJ, Martin, EM, Clark, JC, Thomas, MR, Poulter, NS, Emsley, J, Kellam, B, Watson, SP & Slater, A 2023, 'Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 2, pp. 317-328. https://doi.org/10.1016/j.jtha.2022.11.002

Kardeby, C, Evans, A, Campos, J, Al-Wahaibi, AM, Smith, C, Slater, A, Martin, E, Severin, S, Brill, A, Pejler, G, Sun, Y & Watson, S 2023, 'Heparin and heparin proteoglycan-mimetics activate platelets via PEAR1 and PI3Kβ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 101-116. https://doi.org/10.1016/j.jtha.2022.10.008

Buka, R, Montague, S, Moran, LA, Martin, E, Slater, A, Watson, S & Nicolson, P 2023, 'PF4 activates the c-Mpl-Jak2 pathway in platelets', Blood. https://doi.org/10.1182/blood.2023020872

Jooss, NJ, Smith, CW, Slater, A, Montague, SJ, Di, Y, O'shea, C, Thomas, MR, Henskens, YMC, Heemskerk, JWM, Watson, SP & Poulter, NS 2022, 'Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling and thrombus formation', Journal of Thrombosis and Haemostasis, vol. 20, no. 11, pp. 2617-2631. https://doi.org/10.1111/jth.15836

Maqsood, Z, Clark, JC, Martin, EM, Cheung, YFH, Morán, LA, Watson, SET, Pike, JA, Di, Y, Poulter, NS, Slater, A, Lange, BMH, Nieswandt, B, Eble, JA, Tomlinson, MG, Owen, DM, Stegner, D, Bridge, LJ, Wierling, C & Watson, SP 2022, 'Experimental validation of computerised models of clustering of platelet glycoprotein receptors that signal via tandem SH2 domain proteins', PLoS Computational Biology, vol. 18, no. 11, e1010708. https://doi.org/10.1371/journal.pcbi.1010708

Comment/debate

Slater, A & Jandrot-Perrus, M 2022, 'GPVI and collagen: the final word?', Blood, vol. 139, no. 20, pp. 3005–3007. https://doi.org/10.1182/blood.2022015962

View all publications in research portal